AU3258395A - Estradiol-TTS having water-binding additives - Google Patents

Estradiol-TTS having water-binding additives

Info

Publication number
AU3258395A
AU3258395A AU32583/95A AU3258395A AU3258395A AU 3258395 A AU3258395 A AU 3258395A AU 32583/95 A AU32583/95 A AU 32583/95A AU 3258395 A AU3258395 A AU 3258395A AU 3258395 A AU3258395 A AU 3258395A
Authority
AU
Australia
Prior art keywords
tts
estradiol
water
binding additives
hydrophylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU32583/95A
Other versions
AU700119B2 (en
Inventor
Hanshermann Franke
Michael Horstmann
Walter Muller
Thomas Pontzen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of AU3258395A publication Critical patent/AU3258395A/en
Application granted granted Critical
Publication of AU700119B2 publication Critical patent/AU700119B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention concerns a transdermal therapeutic system which contains oestradiol as active substance and optionally further active substances as well as a hydrophylic additive. The therapeutic system has a layered structure comprising a backing which is impervious to the active substances and moisture, an active substance-containing matrix layer and, depending on the case, a separable protective layer. The system is characterized in that the hydrophylic additive is a component of the matrix.
AU32583/95A 1994-08-20 1995-08-12 Estradiol-TTS having water-binding additives Ceased AU700119B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4429664 1994-08-20
DE4429664A DE4429664C2 (en) 1994-08-20 1994-08-20 Estradiol TTS with water-binding additives and process for its preparation
PCT/EP1995/003202 WO1996005815A1 (en) 1994-08-20 1995-08-12 Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives

Publications (2)

Publication Number Publication Date
AU3258395A true AU3258395A (en) 1996-03-14
AU700119B2 AU700119B2 (en) 1998-12-24

Family

ID=6526229

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32583/95A Ceased AU700119B2 (en) 1994-08-20 1995-08-12 Estradiol-TTS having water-binding additives

Country Status (21)

Country Link
EP (1) EP0776197B1 (en)
JP (1) JPH10504314A (en)
KR (1) KR100374476B1 (en)
CN (1) CN1073413C (en)
AT (1) ATE173163T1 (en)
AU (1) AU700119B2 (en)
CA (1) CA2197865C (en)
CZ (1) CZ50897A3 (en)
DE (2) DE4429664C2 (en)
DK (1) DK0776197T3 (en)
ES (1) ES2126308T3 (en)
FI (1) FI118721B (en)
HU (1) HUT77093A (en)
IL (1) IL114948A (en)
NO (1) NO970553L (en)
NZ (1) NZ291449A (en)
PL (1) PL180943B1 (en)
SI (1) SI0776197T1 (en)
SK (1) SK280299B6 (en)
WO (1) WO1996005815A1 (en)
ZA (1) ZA956926B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6623763B2 (en) 1996-01-08 2003-09-23 Lts Lohmann Therape-System Ag Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organism
DE19600347A1 (en) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Skin-adhering pharmaceutical preparation, in particular TTS for the delivery of 17-beta-estradiol to the human organism
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19827732A1 (en) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermal patch useful for hormone replacement therapy used for treatment of menopausal symptoms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6712090A (en) * 1989-10-13 1991-05-16 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
DE4223360C1 (en) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4237453C1 (en) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4309830C1 (en) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Transdermal patches for oestradiol admin. - contg. isopropylidene mono- or di-glycerol as penetration enhancer

Also Published As

Publication number Publication date
SK280299B6 (en) 1999-11-08
CA2197865C (en) 2005-10-25
KR970705380A (en) 1997-10-09
SI0776197T1 (en) 1999-04-30
KR100374476B1 (en) 2003-04-23
MX9701301A (en) 1998-05-31
IL114948A (en) 2000-10-31
WO1996005815A1 (en) 1996-02-29
ES2126308T3 (en) 1999-03-16
IL114948A0 (en) 1995-12-08
CZ50897A3 (en) 1997-06-11
ATE173163T1 (en) 1998-11-15
PL180943B1 (en) 2001-05-31
SK21997A3 (en) 1997-07-09
AU700119B2 (en) 1998-12-24
CN1155836A (en) 1997-07-30
DE59504233D1 (en) 1998-12-17
DK0776197T3 (en) 1999-07-26
DE4429664C2 (en) 1997-09-11
CN1073413C (en) 2001-10-24
EP0776197B1 (en) 1998-11-11
FI970702A (en) 1997-02-19
PL319014A1 (en) 1997-07-21
EP0776197A1 (en) 1997-06-04
HUT77093A (en) 1998-03-02
DE4429664A1 (en) 1996-02-22
ZA956926B (en) 1996-03-25
NO970553D0 (en) 1997-02-06
NO970553L (en) 1997-02-06
CA2197865A1 (en) 1996-02-29
FI118721B (en) 2008-02-29
NZ291449A (en) 1998-09-24
FI970702A0 (en) 1997-02-19
JPH10504314A (en) 1998-04-28

Similar Documents

Publication Publication Date Title
AU6607898A (en) Transdermal therapeutic system
AU575097B2 (en) Active compound release systems containing polyisobutylenes
MY111126A (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid.
WO1997004818A3 (en) Transdermal therapeutic sysgtem for administering active agents to the human body via the skin
MY111688A (en) Transdermal therapeutic system comprising the active substance 17-b-estradiol (anhydous)
WO1998036740A3 (en) Transdermal or topical plaster system with a polyacrylate matrix with improved physical properties
AU3258395A (en) Estradiol-TTS having water-binding additives
MX9701302A (en) Oestradiol transdermal therapeutic system comprising hygroscopic additives.
AU1176497A (en) Surface-stabilised pharmaceutical preparation for skin application
CA2197867A1 (en) Oestradiol transdermal therapeutic system comprising hygroscopic additives
CA2198092A1 (en) Transdermal therapeutic system with protection against hydrolysis

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired